The company has launched its IPO for the general public from Baisakh 3, with applications open until Baisakh 8.
Sopan Pharmaceuticals Limited has opened its Initial Public Offering (IPO) for the general public starting from Baisakh 3, 2083. The company is issuing a total of 3,474,900 ordinary shares in this phase.
Investors can apply for a minimum of 10 shares and up to a maximum of 11,000 shares. The IPO subscription window will remain open until Baisakh 8, 2083.
The IPO has been issued at a face value of Rs. 100 per share. NMB Capital Limited is serving as the issue and sales manager for the offering.
The company had already completed the allotment of shares reserved for Nepali workers abroad prior to opening the issue for the general public.
The Securities Board of Nepal (SEBON) granted approval for the IPO issuance on Falgun 17, allowing the company to proceed with the public offering.
This article was originally published on https://bajarkochirfar.com. Translated with the help of AI and reviewed by our editorial team.
